Drug General Information
Drug ID
D07ZAH
Former ID
DCL001135
Drug Name
ACH-1625
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [550195]
Company
Achillion
Structure
Download
2D MOL

3D MOL

Formula
C36H53N7O6
Canonical SMILES
CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C<br />)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5
InChI
1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1
InChIKey
BBAWEDCPNXPBQM-GDEBMMAJSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [550195]
References
Ref 550195Clinical pipeline report, company report or official report of Achillion (2011).
Ref 550195Clinical pipeline report, company report or official report of Achillion (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.